RNA Therapeutics Advance Editing and Amplification at 2026 J.P. Morgan Conference
RNA therapeutics drew renewed attention at the 2026 J.P. Morgan Healthcare Conference as companies showcased approaches that edit, repair, and boost gene function without touching DNA. Leaders from